BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2272432)

  • 1. [The surgical treatment of ovarian cancer].
    Burghardt E; Lahousen M; Stettner H
    Geburtshilfe Frauenheilkd; 1990 Sep; 50(9):670-7. PubMed ID: 2272432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The clinical significance of retroperitoneal lymph node metastasis and lymphadenectomy on 3-year survival in ovarian carcinoma].
    Takahashi Y; Akiyama M; Hirose M; Yamamoto Y; Tenzaki T; Ishiguro T; Noda Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Oct; 45(10):1095-100. PubMed ID: 8245587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymph node metastasis in stage I epithelial ovarian cancer.
    Suzuki M; Ohwada M; Yamada T; Kohno T; Sekiguchi I; Sato I
    Gynecol Oncol; 2000 Nov; 79(2):305-8. PubMed ID: 11063662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytoreductive surgery in advanced epithelial cancer of the ovary: the impact of aortic and pelvic lymphadenectomy.
    Spirtos NM; Gross GM; Freddo JL; Ballon SC
    Gynecol Oncol; 1995 Mar; 56(3):345-52. PubMed ID: 7705667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A rational treatment of stage I epithelial ovarian cancer].
    Wang W; Huo R
    Zhonghua Fu Chan Ke Za Zhi; 1996 Jul; 31(7):387-9. PubMed ID: 9275407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Extensive and radical surgery for primary ovarian cancer].
    Chen DX
    Zhonghua Fu Chan Ke Za Zhi; 1992 May; 27(3):165-6, 190. PubMed ID: 1327671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Developments in the therapy of advanced FIGO III ovarian cancer].
    Kuhn W; Jänicke F; Pache L; Hölscher M; Schattenmann G; Schmalfeldt B; Anderl H; Schüle G; Dettmar P; Siewert JR
    Geburtshilfe Frauenheilkd; 1993 May; 53(5):293-302. PubMed ID: 8514099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Radical hysterectomy with pelvic lymphadenectomy in patients with carcinoma of the uterine cervix--3 years' experience].
    Bosković V; Glisić A; Petković S
    Srp Arh Celok Lek; 1998; 126(5-6):183-7. PubMed ID: 9863378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoreductive surgery for stage IV epithelial ovarian cancer.
    Zang RY; Zhang ZY; Cai SM; Li ZT; Chen J; Tang MQ; Liu Q
    J Exp Clin Cancer Res; 1999 Dec; 18(4):449-54. PubMed ID: 10746968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
    Wadler S; Yeap B; Vogl S; Carbone P
    Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epithelial ovarian cancer: impact of surgery and chemotherapy on survival during 1977-1990.
    Venesmaa P
    Obstet Gynecol; 1994 Jul; 84(1):8-11. PubMed ID: 8008329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second-look laparotomy in stage III epithelial ovarian cancer: clinical variables associated with disease status.
    Berek JS; Hacker NF; Lagasse LD; Poth T; Resnick B; Nieberg RK
    Obstet Gynecol; 1984 Aug; 64(2):207-12. PubMed ID: 6539884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of primary cancer of the fallopian tube].
    Pakisch B; Poschauko J; Stücklschweiger G; Poier E; Lahousen M; Pickel H; Kohek P; Klug P; Hackl A
    Geburtshilfe Frauenheilkd; 1990 Aug; 50(8):593-6. PubMed ID: 2210307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of treatment failures and survival of patients with fallopian tube carcinoma: a cooperation task force (CTF) study.
    Gadducci A; Landoni F; Sartori E; Maggino T; Zola P; Gabriele A; Rossi R; Cosio S; Fanucchi A; Tisi G
    Gynecol Oncol; 2001 May; 81(2):150-9. PubMed ID: 11330942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Retroperitoneal lymph node metastasis in patients with ovarian cancer].
    Kasamatsu T; Yoshikawa H; Yokota H; Kume M; Kuwabara Y; Mizuno M
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Apr; 41(4):473-8. PubMed ID: 2746072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
    Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
    Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Personal experiences in the treatment of stage III and IV ovarian cancer].
    Welponer F; Delucca A; Messini S
    Gynakol Rundsch; 1990; 30 Suppl 1():45-8. PubMed ID: 2079298
    [No Abstract]   [Full Text] [Related]  

  • 18. Significance of lymph node sampling in epithelial carcinoma of the ovary.
    Carnino F; Fuda G; Ciccone G; Iskra L; Guercio E; Dadone D; Conte PF
    Gynecol Oncol; 1997 Jun; 65(3):467-72. PubMed ID: 9190977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy.
    Nelson G; Randall M; Sutton G; Moore D; Hurteau J; Look K
    Gynecol Oncol; 1999 Nov; 75(2):211-4. PubMed ID: 10525373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Laparoscopic para-aortic and pelvic lymph node excision--initial experiences and development of a technique].
    Schneider A; Krause N; Kühne-Heid R; Kamprath S; Endisch U; Merker A; Nöschel H
    Zentralbl Gynakol; 1996; 118(9):498-504. PubMed ID: 8992817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.